Hsueh, K.-C.; Lee, C.-C.; Huang, P.-T.; Liang, C.-Y.; Yang, S.-F.
Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis. Curr. Oncol. 2023, 30, 3206-3216.
https://doi.org/10.3390/curroncol30030243
AMA Style
Hsueh K-C, Lee C-C, Huang P-T, Liang C-Y, Yang S-F.
Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis. Current Oncology. 2023; 30(3):3206-3216.
https://doi.org/10.3390/curroncol30030243
Chicago/Turabian Style
Hsueh, Kuan-Chun, Cheng-Chun Lee, Pi-Teh Huang, Chih-Yu Liang, and Shun-Fa Yang.
2023. "Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis" Current Oncology 30, no. 3: 3206-3216.
https://doi.org/10.3390/curroncol30030243
APA Style
Hsueh, K. -C., Lee, C. -C., Huang, P. -T., Liang, C. -Y., & Yang, S. -F.
(2023). Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis. Current Oncology, 30(3), 3206-3216.
https://doi.org/10.3390/curroncol30030243